Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119421) titled 'Effects and Mechanisms of Fucoxanthin in Metabolic Dysfunction-Associated Fatty Liver Disease: An Exploratory Study' on Feb. 26.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Beijing Hospital

Condition: Metabolic Dysfunction-Associated Fatty Liver Disease

Intervention: Treatment group:Fucoxanthin 4mg/d

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-02-28

Target Sample Size: Treatment group:69;Control group:69;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=310717

Published by HT Digital Co...